BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18187039)

  • 1. Caspase cleavage of the MET receptor generates an HGF interfering fragment.
    Deheuninck J; Foveau B; Goormachtigh G; Leroy C; Ji Z; Tulasne D; Fafeur V
    Biochem Biophys Res Commun; 2008 Mar; 367(3):573-7. PubMed ID: 18187039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor.
    Foveau B; Leroy C; Ancot F; Deheuninck J; Ji Z; Fafeur V; Tulasne D
    Cell Death Differ; 2007 Apr; 14(4):752-64. PubMed ID: 17186028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shadow of death on the MET tyrosine kinase receptor.
    Tulasne D; Foveau B
    Cell Death Differ; 2008 Mar; 15(3):427-34. PubMed ID: 17917681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
    Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
    J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage.
    Tulasne D; Deheuninck J; Lourenco FC; Lamballe F; Ji Z; Leroy C; Puchois E; Moumen A; Maina F; Mehlen P; Fafeur V
    Mol Cell Biol; 2004 Dec; 24(23):10328-39. PubMed ID: 15542841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
    Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    Zhang YW; Vande Woude GF
    J Cell Biochem; 2003 Feb; 88(2):408-17. PubMed ID: 12520544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.
    Kirchhofer D; Lipari MT; Santell L; Billeci KL; Maun HR; Sandoval WN; Moran P; Ridgway J; Eigenbrot C; Lazarus RA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5306-11. PubMed ID: 17372204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling.
    Le Goff A; Ji Z; Leclercq B; Bourette RP; Mougel A; Guerardel C; de Launoit Y; Vicogne J; Goormachtigh G; Fafeur V
    J Biol Chem; 2012 Oct; 287(42):35382-35396. PubMed ID: 22915589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the c-Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3.
    Cramer A; Kleiner S; Westermann M; Meissner A; Lange A; Friedrich K
    J Cell Biochem; 2005 Jul; 95(4):805-16. PubMed ID: 15838885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Met receptor tyrosine kinase: enhanced signaling through adapter proteins.
    Furge KA; Zhang YW; Vande Woude GF
    Oncogene; 2000 Nov; 19(49):5582-9. PubMed ID: 11114738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development.
    Ricci G; Catizone A; Galdieri M
    J Endocrinol; 2006 Dec; 191(3):559-70. PubMed ID: 17170214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
    Onimaru Y; Tsukasaki K; Murata K; Imaizumi Y; Choi YL; Hasegawa H; Sugahara K; Yamada Y; Hayashi T; Nakashima M; Taguchi T; Mano H; Kamihira S; Tomonaga M
    Int J Oncol; 2008 Oct; 33(4):697-703. PubMed ID: 18813782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
    Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
    Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrosis- and apoptosis-related Met cleavages have divergent functional consequences.
    Montagne R; Berbon M; Doublet L; Debreuck N; Baranzelli A; Drobecq H; Leroy C; Delhem N; Porte H; Copin MC; Dansin E; Furlan A; Tulasne D
    Cell Death Dis; 2015 May; 6(5):e1769. PubMed ID: 25996296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage.
    Deheuninck J; Goormachtigh G; Foveau B; Ji Z; Leroy C; Ancot F; Villeret V; Tulasne D; Fafeur V
    Cell Signal; 2009 Sep; 21(9):1455-63. PubMed ID: 19450681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K; Nakamura T; Sakai K; Nakamura T
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.